Question 1

Has Mohammed Tirgan received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $9,441 in general payments to Mohammed Tirgan across 94 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Mohammed Tirgan did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Mohammed Tirgan come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Dova Pharmaceuticals	3	$4,405
Pharmacosmos Therapeutics Inc.	1	$3,150
E.r. Squibb & Sons, L.L.C.	7	$192
Incyte Corporation	6	$186
Pharmacyclics LLC, An Abbvie Company	7	$161
Johnson & Johnson(2 entities)	10	$130
Amgen	8	$125
Rigel Pharmaceuticals, Inc.	2	$124
Lilly USA, LLC	6	$122
Comsort, Inc	1	$100
AstraZeneca	5	$81
Sanofi	4	$73
Novartis	4	$72
Merck	5	$71
Seagen Inc.	4	$64
Boehringer Ingelheim	3	$46
Genentech USA, Inc.	3	$44
Bayer	2	$42
Takeda Pharmaceuticals U.S.A., Inc.	2	$42
Eisai Inc.	2	$34
EMD Serono, Inc.	2	$33
Beigene USA, Inc.	1	$33
Gilead	2	$29
Helsinn Therapeutics (U.S.), Inc.	1	$23
Clovis Oncology, Inc.	1	$22
Bristol Myers Squibb	1	$22
Puma Biotechnology, Inc.	1	$16

Mohammed Tirgan

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Other hematology & oncology in Bedford